Non-psychoactive cannabinoid from which THC and CBD are enzymatically derived in the cannabis plant; early preclinical research suggests antibacterial, anti-inflammatory, and neuroprotective activity, though human trial data remain limited.
Chronic systemic inflammation underlies most modern diseases — heart disease, diabetes, autoimmune conditions.
Also known as: Cannabigerol
Every published result for this pair, extracted and audited.
Research volume over time for CBG (Cannabigerol) × inflammation. Structured outcome extraction (direction, effect size) for this pair is in progress - the full analytics will appear here once audited.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Role of the EPA: DHA dosing ratio in omega-3 supplements on blood fatty acid profiles and inflammation: a systematic review and meta-analysisKhabir Z, et al. · Critical reviews in food science and nutrition · 2026PMID 41568426 ↗02Effectiveness of Herbal Medicines with Anti-Inflammatory, Antimicrobial, and Antioxidant Properties in Improving Oral Health and Treating Gingivitis and Periodontitis: A Systematic ReviewMalcangi G, et al. · Nutrients · 2025PMID 40077632 ↗03Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysisGhobadi H, et al. · Inflammopharmacology · 2025PMID 40839182 ↗04The effect of two anti-inflammatory dietary components, omega-3 and resveratrol, on endometriosisBe the first to share what you noticed with CBG (Cannabigerol) for inflammation. How we calculate this.